Hims & Hers Receives Price Target Boost from Bank of America
Bank of America Raises Price Target for Hims & Hers
Bank of America has recently raised its price target for Hims & Hers Health. The new price target is set at $25, up from the previous $23. This adjustment comes as a result of strong core sales trends that suggest there is potential for upside in the company’s upcoming third-quarter revenue.
Optimistic Outlook Amid Deceleration in Growth
Despite witnessing some deceleration in growth during September, analysts from Bank of America maintain a positive outlook on the company's growth trajectory. They have reiterated a Buy rating, indicating confidence in Hims & Hers' future performance.
Sales Growth Trends
According to analysts, Hims observed a year-over-year sales growth decline as indicated by recent Bloomberg Second Measure credit and debit card data. This deceleration occurred after five consecutive months of sales acceleration.
Forecasting Revenue Estimates
Even with the noted slowdown in sales, Bank of America points out that the data suggests a potential upside of 5-8% to the Virginia consensus revenue estimates for the upcoming quarter. This projection takes into account deferred GLP-1 sales, which are crucial for the company.
Impact of GLP-1 Medications
Bank of America highlights the significance of GLP-1 medications—widely recognized for their use in weight loss and diabetes treatment—in Hims & Hers' revenue streams. For the third quarter, these medications are expected to generate revenue between $76 million and $81 million. However, it is important to note that a portion of this revenue, estimated to be between 10% and 20%, is likely to be deferred due to longer-duration subscriptions.
Revenue Projections
This deferral may create a headwind of approximately $8 million to $16 million for the quarter. Consequently, the anticipated revenue range for Q3 is projected to be between $398.5 million and $406.5 million, which is significantly higher than Wall Street's previous forecast of $382.3 million.
Core Operations and Digital Engagement
According to Bank of America, there are encouraging signs regarding Hims & Hers' core operations. The analysts stated that the core growth remains stable and is showing signs of acceleration, which suggests resilience beyond the contributions from GLP-1 medications.
Navigating Competition
It is crucial to consider the competitive landscape, particularly in the weight loss space. The analysts cautioned that if the contributions from GLP-1 medications begin to slow, it could potentially impact future quarters negatively.
Digital Engagement Metrics
In terms of digital engagement, analysts reported a notable 21.9% year-over-year increase in web visits as of September, which marks the third consecutive month of increasing traffic. However, there was some concern as app downloads experienced a decline for the first time in a year, signaling possible changes in user behavior.
Increased Valuation Multiple
Reflecting the strong core trends observed in the business, Bank of America has raised Hims & Hers' valuation multiple from 25x to 27x for the calendar year 2025's EBITDA. This adjustment underscores the bank's confidence in the company's ability to continue on its upward trajectory, emphasizing the factors and trends that contribute to its long-term success.
Frequently Asked Questions
What is the new price target for Hims & Hers set by Bank of America?
The new price target is $25, raised from $23, based on positive sales trends.
How has Hims & Hers’ sales growth changed recently?
Sales growth has decelerated in September after five months of acceleration, according to Bloomberg data.
What impact do GLP-1 medications have on Hims & Hers?
GLP-1 medications are projected to contribute between $76 million and $81 million in Q3 but may face deferred revenue challenges.
How is digital engagement performing for Hims & Hers?
Web visits increased by 21.9% year-over-year in September, but app downloads have declined for the first time in a year.
What is the updated valuation multiple for Hims & Hers?
Bank of America raised the valuation multiple to 27x for CY25 EBITDA, reflecting strong core growth trends.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Genco Shipping & Trading's Upcoming Q3 Conference Call Details
- Flexsteel Industries, Inc. Boosts Sales with Remarkable Q1 Growth
- Rich Steinmeier Takes the Helm as CEO of LPL Financial
- Interparfums Achieves Record Sales in Q3 of 2024
- Investigation of Torrid Holdings Inc. and Its Implications
- Class Action Alert: Investors of Iris Energy Limited Invited
- Transforming Mortgage Experiences: SouthState Bank's Success
- Future Growth of Adhesives and Sealants Market Projected
- Murchinson Calls for Transparency Ahead of Nano Dimension Vote
- Investors Urged to Act Before Orthofix Class Action Deadline
Recent Articles
- Understanding the P/E Ratio of GLOBALFOUNDRIES and Its Impact
- Honeywell Teams Up with Google to Revolutionize Operations
- Tesla’s Future: Navigating Robotaxi Challenges and Market Dynamics
- Analysts Predict Robinhood Markets Stock May Surge Soon
- Top Analyst Picks Highlight Significant Upside in Key Stocks
- Top Stocks Making Waves: Key Market Movers and Trends
- Air Canada Achieves Gold Certification for Workplace Mental Health
- Paragon 28, Inc. Investors Encouraged to Join Class Action Suit
- Investors May Have Class Action Opportunity Against Orthofix
- Lumen and Meta Collaborate to Enhance AI Network Solutions
- Cigna and Humana Resume Merger Talks Amid Market Pressures
- Analyzing Freeport-McMoRan's Upcoming Earnings Release
- 3M Earnings Forecast: Key Metrics and Insights for Investors
- Analyzing 3M's Upcoming Earnings and Market Performance
- Enhancing Child Safety with Innovative Alert Systems
- What to Expect from Enphase Energy's Earnings Report Soon
- Glass Manufacturing Industry Set to Surge Toward $210 Billion
- Enphase Energy Earnings Report Overview: Key Insights and Analysis
- Davidson Kempner Capital Management's Strategic Positioning Insights
- Interpublic Group's Earnings Preview: What to Expect
- Detailed Report of Holdings by Davidson Kempner Capital Management
- What to Expect from Interpublic Group's Upcoming Earnings Release
- Sify Technologies Successfully Meets Nasdaq Listing Standards
- What Investors Should Anticipate from Seagate's Earnings Report
- What Investors Should Know About Seagate Tech's Earnings
- Philip Morris International Prepares for Upcoming Earnings Call
- Experience Luxury and Music with INFINITI and Jon Batiste
- Anticipating Philip Morris Intl's Upcoming Earnings Results
- Key Insights Ahead of Robert Half's Earnings Announcement
- Analyzing Earnings Expectations for Robert Half (RHI)
- Faropoint's Strategic $150M Acquisition Line for Growth
- Exploring PACCAR's Earnings Outlook and Market Position
- Understanding PACCAR's Earnings Dynamics and Market Position
- Class Action Lawsuit for Outset Medical Investors Explained
- Exploring Trade Desk's Remarkable Stock Surge and Future Prospects
- Ncino Inc. Achieves New Milestone with Stock Price Gains
- Elevance Health: Price Target Update and Future Prospects
- Procter & Gamble's Resilience Drives Price Target Increase
- Collaboration Between Medibank and League Promises Digital Evolution
- Fortress Transportation's FTAIO Reaches New High at $26.49
- Allot Communications Reaches New Heights with Robust Growth
- Vertex Pharmaceuticals Receives Positive Outlook from BMO Capital
- Shutterstock Stock Shifts: Analyzing Recent Changes and Trends
- Ares Management Stock Reaches Unprecedented Heights at $171.53
- Westwood Holdings Achieves New Heights with Stock Milestone
- JPMorgan's Climate Initiative: Sarah Kapnick Returns to Lead
- Uber's Strategic Advantage After Tesla's Autonomy Setback
- Discovering Promising AI Stocks for the Future Ahead
- Lumen Technologies Partners with Meta Platforms to Enhance AI Network
- The Gold Craze: Why More Costco Shoppers Are Buying In